Khoi D Nguyen, DO
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 7 carriers
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
29 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$36,884
Medicare paid this office $36,884 for 147 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 50 | $15,524 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,380 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,251 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $3,878 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $1,886 | $20 |
See all 7 services
| Return visit (30+ min) | 50 | $15,524 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,380 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,251 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $3,878 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $1,886 | $20 |
| Short return visit (20+ min) | 15 | $1,076 | $60 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 17 | $372 | $22 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
147 Original Medicare patients in 2024. Average age 76 · Women 54% · Also on Medicaid 46% · Health risk score 1.65. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 33% · Chronic kidney disease 32% · Atrial fibrillation 29% · Heart failure 28% · Dementia 22% · COPD 20% · Cancer 18% · Depression 18% · Stroke 16%.
The office billed $124,083, Medicare allowed $51,670 and paid $36,884; for 480 services of 21 kinds; $494 of it was for drugs given in the office and $36,389 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 147 | 480 | 76 | 1.65 | $124,083 | $36,884 |
| 2023 | 120 | 334 | 78 | 1.52 | $90,034 | $28,599 |
| 2022 | 131 | 350 | 78 | 1.89 | $102,751 | $30,537 |
| 2021 | 152 | 378 | 78 | 2.28 | $112,885 | $33,101 |
| 2020 | 247 | 599 | 76 | 2.77 | $386,598 | $51,282 |
| 2019 | 247 | 600 | 77 | 2.53 | $361,990 | $58,420 |
| 2018 | 181 | 495 | 76 | 2.41 | $213,485 | $53,493 |
| 2017 | 207 | 567 | 78 | 2.78 | $188,482 | $59,676 |
| 2016 | 398 | 1,063 | 76 | 2.33 | $291,257 | $106,113 |
| 2015 | 471 | 1,422 | 75 | 2.18 | $306,526 | $124,391 |
| 2014 | 288 | 954 | 75 | 1.60 | $180,897 | $98,459 |
| 2013 | 332 | 1,257 | 74 | 1.55 | $212,719 | $123,708 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 38 | $12,249 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,292 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,147 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,429 | $102 |
| Short return visit (20+ min) | 12 | $1,386 | $66 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $307 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $297 | $17 |
2022: 8 services
| Return visit (30+ min) | 32 | $10,529 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,415 | $95 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,314 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,671 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,514 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,285 | $176 |
| Short return visit (20+ min) | 13 | $832 | $64 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $776 | $18 |
2021: 8 services
| Return visit (30+ min) | 17 | $8,027 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $6,179 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,032 | $67 |
| Hospital discharge day management, more than 30 minutes | 37 | $3,701 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,821 | $188 |
| Short return visit (20+ min) | 11 | $1,555 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,503 | $116 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $456 | $22 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $22,201 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $6,619 | $132 |
| Hospital discharge day management, more than 30 minutes | 43 | $4,601 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,728 | $196 |
| Hospital discharge day management, 30 minutes or less | 42 | $3,226 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,686 | $99 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,108 | $101 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $910 | $43 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $12,340 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $12,319 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $9,138 | $66 |
| Hospital discharge day management, more than 30 minutes | 88 | $9,010 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,831 | $124 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 15 | $2,960 | $197 |
| Hospital discharge day management, 30 minutes or less | 32 | $2,158 | $67 |
| Hospital observation care on day of discharge | 20 | $1,349 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,100 | $35 |
2018: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $15,025 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $14,386 | $90 |
| Hospital discharge day management, more than 30 minutes | 95 | $9,878 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $5,084 | $63 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 15 | $2,826 | $188 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,411 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,291 | $117 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $22,337 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $17,663 | $173 |
| Hospital discharge day management, more than 30 minutes | 117 | $11,307 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $4,167 | $62 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 11 | $2,060 | $187 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 243 | $46,312 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $23,116 | $161 |
| Hospital discharge day management, more than 30 minutes | 167 | $15,426 | $90 |
| Critical care, first 30-74 minutes | 23 | $8,962 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $3,911 | $58 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 24 | $3,615 | $145 |
| Initial hospital observation care per day, typically 70 minutes | 19 | $2,640 | $139 |
| Hospital observation care on day of discharge | 12 | $687 | $57 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 263 | $49,787 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 119 | $18,423 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 164 | $16,833 | $57 |
| Critical care, first 30-74 minutes | 27 | $13,668 | $175 |
| Hospital discharge day management, more than 30 minutes | 132 | $11,634 | $85 |
| Hospital discharge day management, 30 minutes or less | 87 | $5,167 | $59 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 16 | $2,519 | $148 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,159 | $135 |
| Hospital observation care on day of discharge | 30 | $1,755 | $59 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $33,196 | $83 |
| Critical care, first 30-74 minutes | 44 | $23,136 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $19,745 | $145 |
| Hospital discharge day management, more than 30 minutes | 139 | $12,364 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,768 | $58 |
| Hospital discharge day management, 30 minutes or less | 13 | $764 | $59 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 188 | $40,649 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 174 | $26,716 | $142 |
| Critical care, first 30-74 minutes | 52 | $23,100 | $172 |
| Hospital discharge day management, more than 30 minutes | 207 | $19,254 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $6,599 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $5,548 | $101 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,430 | $57 |
Medicaid work
$4,891 in 2024
Medicaid paid $4,891 for 3,196 billed services this clinician did in 2024, up to 126 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,132 | $2,827 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 90 | $876 |
| OFF/OP EST MAY X REQ PHY/QHP | 791 | $604 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 23 | $165 |
| Short return visit (20+ min) | 656 | $156 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $155 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $109 |
| Short return visit | 178 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 27 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 75 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 200 | $0 |
| 2024 | 3,196 | 11 | 126 | $4,891 |
| 2023 | 4,411 | 20 | 133 | $48,560 |
| 2022 | 3,675 | 20 | 115 | $34,774 |
| 2021 | 2,877 | 22 | 111 | $26,467 |
| 2020 | 1,964 | 16 | 129 | $14,682 |
| 2019 | 1,036 | 13 | 167 | $22,400 |
| 2018 | 166 | 3 | 18 | $4,590 |
See the largest Medicaid services in earlier years
2023
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 258 | $13,964 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 229 | $9,523 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 176 | $6,430 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 112 | $4,817 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 113 | $4,016 |
| Return visit (30+ min) | 1,316 | $3,254 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 130 | $1,188 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 89 | $1,067 |
| OFF/OP EST MAY X REQ PHY/QHP | 672 | $1,035 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 103 | $952 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 84 | $783 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 83 | $754 |
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 199 | $8,584 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 197 | $6,719 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 133 | $4,475 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 296 | $4,424 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 88 | $3,208 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 85 | $2,350 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 54 | $1,799 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 49 | $1,163 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 73 | $595 |
| Return visit (30+ min) | 1,176 | $455 |
| OFF/OP EST MAY X REQ PHY/QHP | 510 | $382 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 26 | $248 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 154 | $5,801 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 104 | $4,292 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 138 | $4,287 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 288 | $3,587 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 161 | $1,932 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 27 | $1,475 |
| Developmental screening | 50 | $1,240 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 12 | $870 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years) | 12 | $665 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 14 | $497 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 13 | $480 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 34 | $451 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 324 | $5,406 |
| Developmental screening | 75 | $2,560 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 54 | $2,079 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 218 | $1,766 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 37 | $1,390 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 25 | $701 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $356 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $179 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 24 | $99 |
| Short return visit (20+ min) | 905 | $74 |
| Return visit (30+ min) | 111 | $41 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 13 | $30 |
2019
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 103 | $7,397 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years) | 114 | $6,891 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 302 | $3,539 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; early childhood (age 1 through 4 years) | 49 | $2,494 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 40 | $782 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $593 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 32 | $317 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 14 | $139 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 13 | $129 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 12 | $119 |
| New patient visit (30+ min) | 159 | $0 |
| New patient visit (45+ min) | 32 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 67 | $1,640 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 61 | $1,479 |
| 1ST HOSP IP/OBS HIGH 75 | 38 | $1,471 |
Drugs they prescribed that Part D paid
$286,007
Pharmacies billed $286,007 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,582 generic and fewer than 11 brand-name prescriptions · $286,007 in drug cost · 47 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 101 | $71,000 | $703 |
| Rybelsus | 37 | $36,482 | $986 |
| Farxiga | 17 | $20,953 | $1,233 |
| Januvia | 22 | $18,244 | $829 |
| Tradjenta | 28 | $15,953 | $570 |
See all 58 drugs
| Jardiance | 101 | $71,000 | $703 |
| Rybelsus | 37 | $36,482 | $986 |
| Farxiga | 17 | $20,953 | $1,233 |
| Januvia | 22 | $18,244 | $829 |
| Tradjenta | 28 | $15,953 | $570 |
| Eliquis | 15 | $15,053 | $1,004 |
| Vascepa | 19 | $4,414 | $232 |
| Valsartan-Hydrochlorothiazide | 53 | $3,611 | $68 |
| Atorvastatin | 331 | $3,546 | $11 |
| Fluticasone Propionate Hfa | 12 | $2,241 | $187 |
| Amlodipine Besylate | 198 | $2,135 | $11 |
| Losartan | 162 | $1,815 | $11 |
| Albuterol Sulfate Hfa | 50 | $1,453 | $29 |
| Tamsulosin | 73 | $1,384 | $19 |
| Metformin | 173 | $1,377 | $8 |
| Metoprolol | 72 | $1,258 | $17 |
| Celecoxib | 27 | $1,141 | $42 |
| Omega-3 Acid Ethyl Esters | 18 | $1,114 | $62 |
| Fenofibrate | 47 | $1,000 | $21 |
| Simvastatin | 44 | $723 | $16 |
| Triamcinolone Acetonide | 75 | $646 | $9 |
| Famotidine | 46 | $584 | $13 |
| Omeprazole | 55 | $530 | $10 |
| Fluocinonide | 13 | $507 | $39 |
| Levothyroxine | 24 | $480 | $20 |
| Betamethasone Diprop Augmented | 15 | $447 | $30 |
| Fluticasone Propionate | 42 | $446 | $11 |
| Alendronate | 47 | $428 | $9 |
| Losartan-Hydrochlorothiazide | 41 | $428 | $10 |
| Rosuvastatin | 35 | $389 | $11 |
| Allopurinol | 53 | $364 | $7 |
| Glipizide | 39 | $363 | $9 |
| Finasteride | 19 | $355 | $19 |
| Diclofenac | 22 | $338 | $15 |
| Pantoprazole | 11 | $333 | $30 |
| Fenofibrate | 15 | $324 | $22 |
| Gabapentin | 32 | $322 | $10 |
| Pravastatin | 16 | $316 | $20 |
| Megestrol Acetate | 14 | $307 | $22 |
| Ezetimibe | 11 | $266 | $24 |
| Carvedilol | 17 | $234 | $14 |
| Enalapril Maleate | 13 | $226 | $17 |
| Metformin Hcl Er | 11 | $186 | $17 |
| Montelukast | 25 | $147 | $6 |
| Chlorhexidine Gluconate | 24 | $120 | $5 |
| Lisinopril | 25 | $107 | $4 |
| Hydrochlorothiazide | 30 | $99 | $3 |
| Metoprolol | 13 | $91 | $7 |
| Atenolol | 27 | $90 | $3 |
| Ibuprofen | 26 | $83 | $3 |
| Benzonatate | 16 | $81 | $5 |
| Clonidine | 17 | $67 | $4 |
| Lovastatin | 11 | $65 | $6 |
| Azithromycin | 21 | $61 | $3 |
| Trazodone | 19 | $61 | $3 |
| Sildenafil Citrate | 13 | $55 | $4 |
| Furosemide | 15 | $53 | $4 |
| Hydralazine | 11 | $35 | $3 |
Year by year
| 2024 | 2,975 | 227 | None | None | $286,007 |
| 2023 | 2,104 | 173 | 1% (20) | 12% | $271,530 |
| 2022 | 1,193 | 116 | None | None | $110,313 |
| 2021 | 472 | 64 | None | 13% | $42,782 |
| 2020 | 345 | 74 | None | None | $39,129 |
| 2019 | 186 | 114 | 9% (17) | 13% | $6,983 |
| 2018 | 210 | 122 | 5% (11) | None | $6,531 |
| 2017 | 254 | 149 | 6% (14) | 12% | $11,827 |
| 2016 | 240 | 123 | 7% (17) | None | $7,313 |
| 2015 | 233 | 112 | 6% (14) | 12% | $4,252 |
| 2014 | 165 | 74 | None | 13% | $4,761 |
| 2013 | 176 | 64 | None | None | $13,367 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Rybelsus | 41 | $66,937 | $1,633 |
| Jardiance | 31 | $25,872 | $835 |
| Creon | 11 | $24,968 | $2,270 |
| Restasis | 17 | $10,702 | $630 |
| Valsartan-Hydrochlorothiazide | 67 | $7,243 | $108 |
| Linzess | 11 | $6,006 | $546 |
| Atorvastatin | 197 | $5,811 | $29 |
| Fenofibrate | 40 | $5,416 | $135 |
| Brilinta | 11 | $5,108 | $464 |
| Amlodipine Besylate | 131 | $2,592 | $20 |
| Metformin | 114 | $2,346 | $21 |
| Celecoxib | 25 | $2,183 | $87 |
| Losartan | 105 | $2,089 | $20 |
| Risedronate Sodium Dr | 11 | $1,736 | $158 |
| Tamsulosin | 43 | $1,382 | $32 |
| Ventolin Hfa | 21 | $1,282 | $61 |
| Diclofenac | 43 | $1,064 | $25 |
| Metoprolol | 34 | $939 | $28 |
| Losartan-Hydrochlorothiazide | 22 | $593 | $27 |
| Rosuvastatin | 20 | $524 | $26 |
| Atenolol | 23 | $478 | $21 |
| Levothyroxine | 18 | $468 | $26 |
| Pantoprazole | 26 | $462 | $18 |
| Glipizide | 22 | $445 | $20 |
| Lisinopril | 25 | $439 | $18 |
| Cyproheptadine | 14 | $383 | $27 |
| Simvastatin | 21 | $379 | $18 |
| Clonidine | 34 | $378 | $11 |
| Oxybutynin Chloride Er | 11 | $364 | $33 |
| Alendronate | 25 | $356 | $14 |
| Allopurinol | 23 | $327 | $14 |
| Gabapentin | 23 | $327 | $14 |
| Sildenafil Citrate | 23 | $302 | $13 |
| Triamcinolone Acetonide | 30 | $298 | $10 |
| Metformin Hcl Er | 18 | $283 | $16 |
| Omeprazole | 23 | $267 | $12 |
| Famotidine | 23 | $240 | $10 |
| Finasteride | 12 | $238 | $20 |
| Montelukast | 20 | $233 | $12 |
| Fluticasone Propionate | 18 | $230 | $13 |
| Pravastatin | 13 | $220 | $17 |
| Chlorhexidine Gluconate | 33 | $212 | $6 |
| Lovastatin | 12 | $176 | $15 |
| Pregabalin | 16 | $172 | $11 |
| Pramipexole Dihydrochloride | 17 | $156 | $9 |
| Metoprolol | 14 | $152 | $11 |
| Hydrochlorothiazide | 21 | $141 | $7 |
| Ibuprofen | 22 | $123 | $6 |
| Azithromycin | 12 | $89 | $7 |
| Zolpidem | 13 | $79 | $6 |
| Trazodone | 13 | $64 | $5 |
| Tramadol | 19 | $44 | $2 |
| Furosemide | 16 | $42 | $3 |
2022: 28 drugs
| Rybelsus | 27 | $41,047 | $1,520 |
| Valsartan-Hydrochlorothiazide | 48 | $3,340 | $70 |
| Atorvastatin | 143 | $2,752 | $19 |
| Metformin | 87 | $1,303 | $15 |
| Ventolin Hfa | 18 | $1,092 | $61 |
| Diclofenac | 35 | $1,088 | $31 |
| Losartan | 65 | $997 | $15 |
| Amlodipine Besylate | 70 | $880 | $13 |
| Losartan-Hydrochlorothiazide | 14 | $442 | $32 |
| Fluticasone Propionate | 29 | $380 | $13 |
| Allopurinol | 24 | $352 | $15 |
| Tamsulosin | 20 | $313 | $16 |
| Alendronate | 25 | $299 | $12 |
| Omeprazole | 26 | $277 | $11 |
| Metoprolol | 12 | $261 | $22 |
| Gabapentin | 27 | $247 | $9 |
| Lisinopril | 18 | $220 | $12 |
| Rosuvastatin | 15 | $194 | $13 |
| Triamcinolone Acetonide | 14 | $189 | $13 |
| Clonidine | 11 | $165 | $15 |
| Simvastatin | 15 | $155 | $10 |
| Chlorhexidine Gluconate | 22 | $131 | $6 |
| Glipizide | 13 | $116 | $9 |
| Pantoprazole | 16 | $115 | $7 |
| Hydrochlorothiazide | 15 | $115 | $8 |
| Hydrocortisone | 11 | $112 | $10 |
| Lovastatin | 11 | $100 | $9 |
| Metoprolol | 11 | $69 | $6 |
2021: 9 drugs
| Atorvastatin | 46 | $742 | $16 |
| Valsartan-Hydrochlorothiazide | 12 | $709 | $59 |
| Diclofenac | 11 | $281 | $26 |
| Losartan | 28 | $261 | $9 |
| Allopurinol | 11 | $256 | $23 |
| Metformin | 32 | $248 | $8 |
| Lovastatin | 13 | $121 | $9 |
| Amlodipine Besylate | 23 | $119 | $5 |
| Hydrochlorothiazide | 15 | $112 | $7 |
2020: 5 drugs
| Atorvastatin | 37 | $577 | $16 |
| Amlodipine Besylate | 24 | $173 | $7 |
| Cephalexin | 11 | $73 | $7 |
| Omeprazole | 12 | $56 | $5 |
| Metformin | 11 | $31 | $3 |
2019: 3 drugs
| Amoxicillin-Clavulanate Potass | 15 | $188 | $13 |
| Levofloxacin | 12 | $115 | $10 |
| Cephalexin | 14 | $77 | $5 |
2018: 4 drugs
| Ampicillin-Sulbactam | 15 | $560 | $37 |
| Levofloxacin | 22 | $259 | $12 |
| Amoxicillin-Clavulanate Potass | 17 | $189 | $11 |
| Cephalexin | 19 | $120 | $6 |
2017: 5 drugs
| Levofloxacin | 29 | $305 | $11 |
| Metronidazole | 13 | $164 | $13 |
| Amoxicillin-Clavulanate Potass | 15 | $150 | $10 |
| Cephalexin | 14 | $82 | $6 |
| Furosemide | 11 | $41 | $4 |
2016: 3 drugs
| Amoxicillin-Clavulanate Potass | 12 | $148 | $12 |
| Cephalexin | 15 | $89 | $6 |
| Carvedilol | 12 | $73 | $6 |
2015: 4 drugs
| Levofloxacin | 14 | $113 | $8 |
| Hydrocodone-Acetaminophen | 11 | $104 | $9 |
| Ciprofloxacin | 13 | $95 | $7 |
| Prednisone | 15 | $79 | $5 |
2014: 1 drug
| Prednisone | 14 | $74 | $5 |
2013: 1 drug
| Atorvastatin | 12 | $133 | $11 |
Money from drug and device companies
$132 in 2025
| 2025 | 1 | 1 | None | $132 |
| 2024 | 4 | 5 | None | $293 |
| 2023 | 2 | 14 | None | $264 |
| 2021 | 1 | 1 | None | $14 |
| 2019 | 1 | 1 | None | $26 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $132 | 1 payment
|
See the published payment
| Shockwave Medical | Meals · 2025-03-27 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $132 |
See earlier years (2024, 2023, 2021, 2019)
2024: $293
| GlaxoSmithKline | Arexvy | $122 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $121 | 1 payment
|
| Medtronic | Micra | $30 | 2 payments
|
| Sandoz | Hyrimoz | $20 | 1 payment
|
2023: $264
| Abiomed | Impella | $245 | 13 payments
|
| GlaxoSmithKline | Bexsero | $19 | 1 payment
|
2021: $14
| Abiomed | Impella | $14 | 1 payment
|
2019: $26
| GlaxoSmithKline | Bexsero | $26 | 1 payment
|
Professional record
- NPI
- 1003141102
- Licence
- CA 20A 11589
- Trained
- New York College of Osteo Medicine of New York Institute of Technology, 2007
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1295 Fulbar Ct, San Jose, CA, 95132
- NPI first listed
- 2009-10-07
- NPI last updated
- 2013-02-14
This is when the NPI record was last certified, not a medical board exam.